{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T04:22:39Z","timestamp":1784002959394,"version":"3.55.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:00:00Z","timestamp":1718755200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["FS\/SBSRF\/22\/31031"],"award-info":[{"award-number":["FS\/SBSRF\/22\/31031"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC-PC-17183"],"award-info":[{"award-number":["MC-PC-17183"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000855","name":"University of Birmingham","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS\/SBSRF\/22\/31031"],"award-info":[{"award-number":["FS\/SBSRF\/22\/31031"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/19\/87\/34792"],"award-info":[{"award-number":["PG\/19\/87\/34792"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/23\/11579"],"award-info":[{"award-number":["PG\/23\/11579"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.vph.2024.107399","type":"journal-article","created":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T19:35:03Z","timestamp":1718739303000},"page":"107399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Fluorinated perhexiline derivative attenuates vascular proliferation in pulmonary arterial hypertension smooth muscle cells"],"prefix":"10.1016","volume":"156","author":[{"given":"Kayleigh","family":"Griffiths","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger J.","family":"Grand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Horan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelangelo","family":"Certo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross C.","family":"Keeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Mauro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Chung","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain","family":"Greig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas W.","family":"Morrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Zanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Frenneaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Madhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2024.107399_bb0005","article-title":"Pulmonary arterial hypertension: pathogenesis and clinical management","volume":"360","author":"Thenappan","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.vph.2024.107399_bb0010","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cca.2016.07.017","article-title":"The Warburg effect: a new story in pulmonary arterial hypertension","volume":"461","author":"Peng","year":"2016","journal-title":"Clin. Chim. Acta"},{"issue":"19","key":"10.1016\/j.vph.2024.107399_bb0015","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1161\/CIRCULATIONAHA.114.006979","article-title":"Emerging concepts in the molecular basis of pulmonary arterial hypertension. Part I: Metabolic plasticity and mitochondrial dynamics in the pulmonary circulation and right ventricle in pulmonary arterial hypertension","volume":"131","author":"Ryan","year":"2015","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.vph.2024.107399_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10061415","article-title":"The potential application and promising role of targeted therapy in pulmonary arterial hypertension","volume":"10","author":"Hsieh","year":"2022","journal-title":"Biomedicines"},{"issue":"8","key":"10.1016\/j.vph.2024.107399_bb0025","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00109-011-0762-2","article-title":"Pyruvate dehydrogenase inhibition by the inflammatory cytokine TNF\u03b1 contributes to the pathogenesis of pulmonary arterial hypertension","volume":"89","author":"Sutendra","year":"2011","journal-title":"J. Mol. Med."},{"issue":"3","key":"10.1016\/j.vph.2024.107399_bb0030","first-page":"1391","article-title":"Reversal of the Warburg effect with DCA in PDGF-treated human PASMC is potentiated by pyruvate dehydrogenase kinase-1 inhibition mediated through blocking Akt\/GSK-3\u03b2 signalling","volume":"42","author":"Li","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.vph.2024.107399_bb0035","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00109-009-0524-6","article-title":"The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle","volume":"88","author":"Piao","year":"2010","journal-title":"J. Mol. Med."},{"issue":"3","key":"10.1016\/j.vph.2024.107399_bb0040","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1212\/01.wnl.0000196641.05913.27","article-title":"Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial","volume":"66","author":"Kaufmann","year":"2006","journal-title":"Neurology"},{"issue":"44","key":"10.1016\/j.vph.2024.107399_bb0045","doi-asserted-by":"crossref","first-page":"44ra58","DOI":"10.1126\/scitranslmed.3001327","article-title":"Fatty acid oxidation and malonyl-CoA decarboxylase in the vascular remodeling of pulmonary hypertension","volume":"2","author":"Sutendra","year":"2010","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.vph.2024.107399_bb0050","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0006-2952(96)00204-3","article-title":"Inhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodarone","volume":"52","author":"Kennedy","year":"1996","journal-title":"Biochem. Pharmacol."},{"issue":"21","key":"10.1016\/j.vph.2024.107399_bb0055","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1161\/CIRCULATIONAHA.105.551457","article-title":"Metabolic modulation with perhexiline in chronic heart failure: a randomized, controlled trial of short-term use of a novel treatment","volume":"112","author":"Lee","year":"2005","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.vph.2024.107399_bb0060","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1161\/CIRCULATIONAHA.109.934059","article-title":"Metabolic modulator perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathy","volume":"122","author":"Abozguia","year":"2010","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.vph.2024.107399_bb0065","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-2125.2005.02570.x","article-title":"The influence of CYP2D6 genotype on trough plasma perhexiline and cis-OH-perhexiline concentrations following a standard loading regimen in patients with myocardial ischaemia","volume":"61","author":"Davies","year":"2006","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"7","key":"10.1016\/j.vph.2024.107399_bb0070","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1021\/acs.jmedchem.6b01592","article-title":"Development of fluorinated analogues of Perhexiline with improved pharmacokinetic properties and retained efficacy","volume":"60","author":"Tseng","year":"2017","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.vph.2024.107399_bb0075","doi-asserted-by":"crossref","first-page":"13738","DOI":"10.3390\/ijms150813738","article-title":"BMP4 protects rat pulmonary arterial smooth muscle cells from apoptosis by PI3K\/AKT\/Smad1\/5\/8 signaling","volume":"15","author":"Wu","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.vph.2024.107399_bb0080","first-page":"L354","article-title":"PI3K is required for proliferation and migration of human pulmonary vascular smooth muscle cells","volume":"283","author":"Goncharova","year":"2002","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"issue":"6","key":"10.1016\/j.vph.2024.107399_bb0085","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3109\/10799893.2015.1030412","article-title":"Signaling pathway of MAPK\/ERK in cell proliferation, differentiation, migration, senescence and apoptosis","volume":"35","author":"Sun","year":"2015","journal-title":"J. Recept. Signal Transduct. Res."},{"issue":"6","key":"10.1016\/j.vph.2024.107399_bb0090","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1159\/000374015","article-title":"Modulation of pulmonary vascular remodeling in hypoxia: role of 15-LOX-2\/15-HETE-MAPKs pathway","volume":"35","author":"Yu","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"issue":"25","key":"10.1016\/j.vph.2024.107399_bb0095","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1161\/01.CIR.102.25.3130","article-title":"Prostacyclin analogues differentially inhibit growth of distal and proximal human pulmonary artery smooth muscle cells","volume":"102","author":"Wharton","year":"2000","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.vph.2024.107399_bb0100","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s41401-019-0272-2","article-title":"Crosstalk between the Akt\/mTORC1 and NF-kappaB signaling pathways promotes hypoxia-induced pulmonary hypertension by increasing DPP4 expression in PASMCs","volume":"40","author":"Li","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"issue":"13","key":"10.1016\/j.vph.2024.107399_bb0105","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1093\/hmg\/ddz047","article-title":"BMPRII deficiency impairs apoptosis via the BMPRII-ALK1-BclX-mediated pathway in pulmonary arterial hypertension","volume":"28","author":"Chowdhury","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.vph.2024.107399_bb0110","doi-asserted-by":"crossref","first-page":"14079","DOI":"10.1038\/ncomms14079","article-title":"TNFalpha drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signalling","volume":"8","author":"Hurst","year":"2017","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.vph.2024.107399_bb0115","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/cvr\/cvy087","article-title":"Nitrite circumvents platelet resistance to nitric oxide in patients with heart failure preserved ejection fraction and chronic atrial fibrillation","volume":"114","author":"Borgognone","year":"2018","journal-title":"Cardiovasc. Res."},{"issue":"8","key":"10.1016\/j.vph.2024.107399_bb0120","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nrcardio.2011.87","article-title":"Mechanisms of disease: pulmonary arterial hypertension","volume":"8","author":"Schermuly","year":"2011","journal-title":"Nat. Rev. Cardiol."},{"issue":"1","key":"10.1016\/j.vph.2024.107399_bb0125","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.yexcr.2019.02.022","article-title":"Inhibition of Src activation reverses pulmonary vascular remodeling in experimental pulmonary arterial hypertension via Akt\/mTOR\/HIF-1<alpha> signaling pathway","volume":"380","author":"Liu","year":"2019","journal-title":"Exp. Cell Res."},{"issue":"12","key":"10.1016\/j.vph.2024.107399_bb0130","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1111\/bph.13480","article-title":"Present and future pharmacotherapeutic agents in heart failure: an evolving paradigm","volume":"173","author":"Loudon","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.vph.2024.107399_bb0135","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pharmthera.2017.08.001","article-title":"Cardiac metabolism \u2014 a promising therapeutic target for heart failure","volume":"182","author":"Noordali","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"8","key":"10.1016\/j.vph.2024.107399_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28083624","article-title":"Perhexiline: old drug, new tricks? A summary of its anti-Cancer effects","volume":"28","author":"Dhakal","year":"2023","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.vph.2024.107399_bb0145","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1527-3466.2007.00006.x","article-title":"Perhexiline","volume":"25","author":"Ashrafian","year":"2007","journal-title":"Cardiovasc. Drug Rev."},{"issue":"12","key":"10.1016\/j.vph.2024.107399_bb0150","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1161\/CIRCRESAHA.120.316443","article-title":"Epigenetic metabolic reprogramming of right ventricular fibroblasts in pulmonary arterial hypertension: a pyruvate dehydrogenase kinase-dependent shift in mitochondrial metabolism promotes right ventricular fibrosis","volume":"126","author":"Tian","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2024.107399_bb0155","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11010-015-2553-5","article-title":"Activation of the phosphatidylinositol 3-kinase\/Akt pathway is involved in lipocalin-2-promoted human pulmonary artery smooth muscle cell proliferation","volume":"410","author":"Wang","year":"2015","journal-title":"Mol. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.vph.2024.107399_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2020.112392","article-title":"Plasminogen activator Inhibitor-2 inhibits pulmonary arterial smooth muscle cell proliferation in pulmonary arterial hypertension via PI3K\/Akt and ERK signaling","volume":"398","author":"Zhang","year":"2021","journal-title":"Exp. Cell Res."},{"issue":"5","key":"10.1016\/j.vph.2024.107399_bb0165","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3748\/wjg.v11.i5.623","article-title":"Increased expression of mitogen-activated protein kinase and its upstream regulating signal in human gastric cancer","volume":"11","author":"Liang","year":"2005","journal-title":"World J. Gastroenterol."},{"issue":"12","key":"10.1016\/j.vph.2024.107399_bb0170","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.1091\/mbc.e07-04-0391","article-title":"Hypoxia up-regulates hypoxia-inducible factor-1alpha transcription by involving phosphatidylinositol 3-kinase and nuclear factor kappaB in pulmonary artery smooth muscle cells","volume":"18","author":"BelAiba","year":"2007","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.vph.2024.107399_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109353","article-title":"A mechanism of perhexiline\u2019s cytotoxicity in hepatic cells involves endoplasmic reticulum stress and p38 signaling pathway","volume":"334","author":"Ren","year":"2021","journal-title":"Chem. Biol. Interact."},{"issue":"4","key":"10.1016\/j.vph.2024.107399_bb0180","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1159\/000479401","article-title":"PDGF promotes the Warburg effect in pulmonary arterial smooth muscle cells via activation of the PI3K\/AKT\/mTOR\/HIF-1\u03b1 signaling pathway","volume":"42","author":"Xiao","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"issue":"2","key":"10.1016\/j.vph.2024.107399_bb0185","first-page":"L256","article-title":"Endothelial HIF-2alpha contributes to severe pulmonary hypertension due to endothelial-to-mesenchymal transition","volume":"314","author":"Tang","year":"2018","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"issue":"2","key":"10.1016\/j.vph.2024.107399_bb0190","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1096\/fj.201600557R","article-title":"Loss of smooth muscle cell hypoxia inducible factor-1\u03b1 underlies increased vascular contractility in pulmonary hypertension","volume":"31","author":"Barnes","year":"2017","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.vph.2024.107399_bb0195","first-page":"L422","article-title":"Pulmonary artery smooth muscle cell HIF-1\u03b1 regulates endothelin expression via microRNA-543","volume":"315","author":"Wang","year":"2018","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"issue":"2","key":"10.1016\/j.vph.2024.107399_bb0200","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ccell.2016.07.004","article-title":"Mitochondrial Akt regulation of hypoxic tumor reprogramming","volume":"30","author":"Chae","year":"2016","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.vph.2024.107399_bb0205","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s12013-011-9332-z","article-title":"Dysregulation of PTEN in cardiopulmonary vascular remodeling induced by pulmonary hypertension","volume":"67","author":"Ravi","year":"2013","journal-title":"Cell Biochem. Biophys."},{"issue":"24","key":"10.1016\/j.vph.2024.107399_bb0210","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.7150\/jca.34650","article-title":"Dichloroacetate overcomes Oxaliplatin Chemoresistance in colorectal Cancer through the miR-543\/PTEN\/Akt\/mTOR pathway","volume":"10","author":"Liang","year":"2019","journal-title":"J. Cancer"},{"issue":"6","key":"10.1016\/j.vph.2024.107399_bb0215","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1164\/rccm.200709-1369PP","article-title":"The cancer paradigm of severe pulmonary arterial hypertension","volume":"178","author":"Rai","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"25","key":"10.1016\/j.vph.2024.107399_bb0220","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1161\/CIRCULATIONAHA.117.031655","article-title":"Pyruvate kinase and Warburg metabolism in pulmonary arterial hypertension: uncoupled glycolysis and the Cancer-like phenotype of pulmonary arterial hypertension","volume":"136","author":"Archer","year":"2017","journal-title":"Circulation"},{"issue":"413","key":"10.1016\/j.vph.2024.107399_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.aao4583","article-title":"Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patients","volume":"9","author":"Michelakis","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.vph.2024.107399_bb0230","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.RES.86.5.580","article-title":"The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase","volume":"86","author":"Kantor","year":"2000","journal-title":"Circ. Res."},{"issue":"9","key":"10.1016\/j.vph.2024.107399_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007124","article-title":"Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling","volume":"4","author":"Balgi","year":"2009","journal-title":"PLoS One"},{"issue":"1\u20133","key":"10.1016\/j.vph.2024.107399_bb0240","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejphar.2005.11.058","article-title":"Effect of the anti-anginal agent, perhexiline, on neutrophil, valvular and vascular superoxide formation","volume":"531","author":"Kennedy","year":"2006","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.vph.2024.107399_bb0245","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/ejcts\/ezu238","article-title":"Investigators, the effect of perhexiline on myocardial protection during coronary artery surgery: a two-Centre, randomized, double-blind, placebo-controlled trial","volume":"47","author":"Drury","year":"2015","journal-title":"Eur. J. Cardiothorac. Surg."},{"issue":"8","key":"10.1016\/j.vph.2024.107399_bb0250","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1161\/01.RES.0000145360.16770.9f","article-title":"Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis","volume":"95","author":"McMurtry","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2024.107399_bb0255","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1471-2121-14-32","article-title":"Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis","volume":"14","author":"Brentnall","year":"2013","journal-title":"BMC Cell Biol."},{"key":"10.1016\/j.vph.2024.107399_bb0260","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.lfs.2016.03.044","article-title":"Antagonists to endothelin receptor type B promote apoptosis in human pulmonary arterial smooth muscle cells","volume":"159","author":"Sakai","year":"2016","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.vph.2024.107399_bb0265","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/bph.15016","article-title":"Current and future treatments of pulmonary arterial hypertension","volume":"178","author":"Sommer","year":"2021","journal-title":"Br. J. Pharmacol."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189124001253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189124001253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:26:24Z","timestamp":1778617584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189124001253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":53,"alternative-id":["S1537189124001253"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2024.107399","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluorinated perhexiline derivative attenuates vascular proliferation in pulmonary arterial hypertension smooth muscle cells","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2024.107399","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107399"}}